Gaia Agora

GAIA focuses on developing evidence-based, safe, and accessible digital therapeutics to help patients restore and maintain their physical and mental well-being. The company’s digital therapeutics span multiple areas including neuroscience, immunology, oncology, and behavioral health. GAIA is one of the largest and most experienced digital healthcare companies globally, with a mission to develop digital therapeutics that offer effect sizes, safety profiles, and levels of convenience equivalent to well-established pharmaceutical solutions for doctors, therapists, payers, and patients. We have a multidisciplinary team of experts covering all capabilities required to develop, launch, and maintain first-class products for major markets. Our team includes experienced physicians and psychotherapists, clinical scientists skilled in conducting Phase II and Phase III trials, IT and software engineers, regulatory affairs specialists, and market access experts.